Five cases of zygomycosis;Zigomicosis. A proposito de cinco casos

Revista Iberoamericana de Micologia

Volumn 16, Issue 1, 1999, Pages 50-56

  Del Palacio, Amalia ^a   Ramos, Ma José ^a   Pérez, Ana ^a   Arribi, Ana ^a   Amondarain, Izaskun ^a   Alonso, Soledad ^a   Ortíz, Ma Cruz ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Absidia corymbifera; Deep fungal infection; Liposomal amphotericin B; Mucor circinelloides; Rhizomucor pusillus; Rhizopus stolonifer; Zygomycetes

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOSPORIN;

ABSIDIA; ACIDOSIS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MUCOR; MUCORMYCOSIS; NEUTROPENIA; RHIZOPUS; SKIN MANIFESTATION;

EID: 0032919747     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gregory JE, Golden A, Haymaker W. Mucormycosis of the central nervous system: report of three cases. Bull John Hopkins Hosp 1943; 73: 405-419
2. a ed. Washington DC, American Society for Microbiology, 1995: 809-824.
3. Ajello L, Dean DJ, Irwin RS. The zygomicete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. Mycología 1976; 68: 52-62.
4. Sands JM, Macher AM, Ley TJ, Nienhuis AW. Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalasemia Case report and review of the literature Ann Intern Med 1985; 102: 59-63.
5. Mostaza JM, Barbado FJ, Fernández Martín J, Peña Yañez J, Vázquez Rodríguez JJ, Cutaneoarticular mucormycosis due to Cunninghamella bertholletiae in a patient with AIDS Rev Infect Dis 1989; 11: 316-318.
6. Misra PC, Srivastava KJ, Lata K Apophysomyces: a new genus of the mucorales Mycotaxon 1979; 8: 377-382.
7. Cooter RD, Lim IS, Ellis DH, Leitch IOW. Burn wound zygomycosis by Apophysomyces elegans. J Clin Microbiol 1990; 28: 2151-2153.
8. Kamalam A, Thambia SS Cutaneous infection by Syncephalastrum. Sabourandia 1980; 273-277.
9. Lehrer RI, Howard DH, Sypherd PS, Edward JE, Segal GP, Winston DJ. Mucormycosis. Ann Intern Med 1980; 93: 93-108.
10. 10.NCCLS. Reference method for broth difution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A NCCLS, Wayne, Pennsylvania, 1997.
11. Rippon JW. Zygomicosis En: Medical Micology (3rd ed). Philadelphia, Saunders Co, 1988: 681-713.
12. Sugar AM. Agents of mucormycosis and related species. En: Mandell GL, Bennett JE, Dolin R (Eds) Principles and practice of infectious diseases. New York, Churchill Livingstone, 1995: 2311-2321
13. Parfrey N. Improved diagnosis and prognosis of mucormycosis. Medicine 1986; 65: 113-123.
14. Kaufman L, Mendoza L, Standard PG. Inmunodifusion test for diagnosis of subcutaneous zygomycosis. J Clin Microbiol 1990; 28: 1887-1890.
15. Pierce PF, Solomon SI, Kaufman L. Zigomycete brain abscess in narcotic addicts with serological diagnosis. J Am Med As 1982; 248: 2881-2882.
16. Torres Rodríguez JM, del Palacio Hernanz A, Guarro Artigas J, Negroni Briz R, Pereiro Miguens M (Eds.) Micología Médica. Barcelona, Masson, 1993: 315-324.
17. González A, del Palacio A, Cuétara MS, Gómez C, Carabias E, Malo Q. Zigomicosis: revisión de 16 casos. Enferm Infecc Microbiol Clin 1996, 14 233-239.
18. Odds FC, Aral T, Disalvo AF. Nomenclature of fungal diseases a report and recommendations from a sub-committee of the International Society for Human and Animal Mycology (ISHAM). J Med Vet Mycol 1992; 30: 1-10
19. Baker RD, Linares G. Prednisone induced mucormycosis in rhesus monkeys. Sabourandia 1974; 12: 75-80.
20. Gartenberg G, Bottone EJ, Keusch TG, Weitzman I. Hospital acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue Epidemiology, mycology and treatment. N Engl J Med 1978; 299: 824-828.
21. del Palacio Hernanz A, Delgado Vazquez R, Bernardo de Quirós JC, Pérez Revilla A, Martín Rabadán Caballero P Cinco casos de zigomicosis en un hospital general. Estudio epidemiológico de un posible origen nosocomial. Rev Iber Micol 1987; 4:135-148.
22. Dennis JE, Rhodes KH, Cooney DR, Roberts GD. Nosocomial Rhizopus infection (zygomycosis) in children. J Pediatr 1980; 96: 825-828.
23. Mitchell SJ, Gray J, Morgan MEI, Hocking MD, Durbin GM. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet 1996; 348 441-443.
24. del Palacio Hernanz A, Fereres J Larregla Garrans S, Rodríguez-Noriega A, Sanz Sanz F. Nosocomial Infection by Rhizomucor pusillus in a clinical haematology unit. J Hosp Infec 1983; 14: 45-49.
25. St-Germain G, Robert A, Ishak M, Tremblay C, Claveau S. Infection due to Rhizomucor pusillus: report of four cases in patients with leukemia and review. Clin Infect Dis 1993; 16: 640-645.
26. Adam RD, Hunter G, Di Tomasso J, Comesci G. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994; 19 67-76.
27. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience Rev Infect Dis 1990; 12: 308-329.
28. Perfect JL, Lidsay MH, Drew RH. Adverse drug reactions to systemic antifungals: prevention and management Drug Safety 1992; 7: 323-363
29. Pahissa A. Anfotericina B complejo lipídico versus liposómica ¿Cuál, por qué, cuándo? Enferm Infecc Microbiol Clin 1997; 15: 1-3.
30. Tollemar J, Ringden O. Lipid formulations of amphotericin B. Less toxicity but at what economic cost? Drug Safety 1995, 13: 207-218